The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 13 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 13 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 13
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
Catherine Duggan, CEO FIP, Netherlands

Panellists:
-Mahmoud Abdelrahman, President Egyptian Foundation of Clinical pharmacy EFCP, Egypt
- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP Australia
- Ramesh Walpola, Senior Lecturer School of Population Health, UNSW Sydney, Australia
-Virginia Olmos, Vice President AQFU, Uruguay
- Subhash Mandal, Vice President Indian Pharmaceutical Association, India
- Ema Paulino, FIP Professional Secretary, Policy committee for statement on Women and RUM (Chair) Portugal
-Eeva Teräsalmi, FIP Foundation Director Immediate Past Vice President of FIP, Finland
-Allie Jo Shipman Director, YPG Liaison to FIP Community Pharmacy Section,USA
-Luna Elbizri, Founder and Manager, Lunapharm Pharmacy, Lebanon
-Mariet Eksteen, Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa

Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines.
Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines.
2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications.
3- to identify emerging regional and global threats and challenges related to counterfeit medication.

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1. Describe the characteristics and epidemiology of the main VBDs in the European region;
2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and
3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.

Moderator:
- Sari Westermarck, Community pharmacist - Finland

Panellists:
- Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes - Denmark
- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia - Spain
- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology - Turkey
- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union - Bulgaria

This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

About the programme:
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

Moderator:
- Catherine Duggan - CEO of FIP - The Netherlands

Co-Moderator:
- Eduardo Savio – President of the Pharmaceutical Forum of the Americas

Panellists:
- Daphne Holt - Chair of Coalition for Life-course Immunisation - UK
- Meghna Joshi-Von Heyden - Strategic Development Advisor of Commonwealth Pharmacists Association (CPA) - Switzerland
- Bhojraj Suresh - Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru - India
- Marleen Haems - Director at the Royal East Flemish Pharmacists' Guild (KOVAG) – Belgium
- Katarina Milosevic Konstadinovic - Chairman of Assembly of Pharmaceutical Chamber of Montenegro - Montenegro

Like most people, health professionals experience illness and have family obligations and other commitments outside their professional lives that can affect their mental health. Unlike most people, however, health professionals are also exposed to a particular mix of occupational pressures that can pose additional risks to their mental well-being. Rates of poor mental health in health professionals appear to be increasing in response to rising demands, staffing shortages and diminishing resources. In addition, mental health stresses have been rising during the COVID-19 pandemic.

During this webinar the World Health Professions Alliance are bringing together a range of experts in mental health and the workforce to better understand what the issues are and how we can all work together to support our workforce and look after ourselves.

This event will describe Development Goal 12: Pharmacy Intelligence and explore latest developments in data and intelligence that supports health care. It will identify practical approaches to progress towards Development Goal 12.

Aim:
To discuss development goal 12 and how to ensure it supports health care.

Learning objectives:
1. Define pharmacy intelligence and explain priorities for its development (FIP Development Goal 12)
2. Discuss approaches to community pharmacy data collection
3. Explain the METNA project and its approach to data collection and needs assessment
4. List the functions of the GPO Atlas
5. Analyse and comment on possible indicators for DG12

Moderator
Professor Robert Sindelar, Chair – One FIP Data and Intelligence Commission

Panelists and Speakers
- Chris John, Lead for Data and Intelligence, FIP
- António Rodrigues, Executive Director - Portuguese Association of Pharmacies
- Farah Aqqad, Regional Engagement and Project Coordinator, FIP
- Dr Mira Zugic, President of the Pharmaceutical Chamber of Montenegro
- Dr Tanniru Narayana/Dr Rao Vadlamudi – Indian Pharmaceutical Association
- Mr. Nurul Falah Eddy Pariang, President – Indonesian Pharmacists Association.
- Sherly Meilianti, Data and Intelligence Specialist, FIP

FIP Technology Forum brings you the webinar about Virtual reality (VR). VR has been widely studied and applied in numerous medical applications. In pharmacy, VR can potentially be applied in wide range of activities, from drug design and discovery, though pharmacist education, to in-patient counseling and behavior modification. In this webinar we bring you the examples of VR technology applications in pharmacy. In our webinar, we will showcase and immersive virtual reality in a virtual environment with experience from Finland with our speaker Mia Siven from Helsinki University, where the VR was successfully applied in pharmacy education. We will then present a showcase of immersive virtual reality in a real environment, with speakers Agnes Bobay Madic and Paul Besnier with their example from France. VR technology has become increasingly affordable, flexible, and portable, enabling its use for therapeutic purposes in both inpatient and outpatient environments. But despite the compelling features of VR, a number of challenges exist, such as validation of clinical efficacy, cost/accessibility and usability issues, technical capabilities, acceptance, among others. You will have the opportunity to ask questions in the panel discussion part of the webinar.

Moderator:
-Jacqueline Surugue, FIP Vice President, Hospital Pharmacist, France
Panellists:
-Eeva Teräsalmi, Community Pharmacist, Owner Seven Brothers Pharmacy, Helsinki, Finland
-Mia Siven, FIP Technology Forum Chair Vice-Dean, University of Helsinki, Finland
-Agnès Bobay-Madic. Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
-Paul Besnier, Pharmacy Intern, Centre Hospitalier Universitaire de Caen Normandie, France

mRNA technology was used in developing the first ever COVID vaccine, developed by Pfizer / BioNtech. A number of vaccine or therapeutic products are in developing this technology. This webinare will address the following:

• What is mRNA? (structure and chemistry)
• How does it work in a cell (as either a therapeutic or vaccine)?
• How is it made and at what scale?
• How is it analyzed and characterized?
• By what means can it be delivered to the patient?
• What were the biggest challenges to get mRNA vaccines out to the public in 2020?
• What other notable clinical advances have been made for mRNA based medicines?
• What future directions do we see for mRNA as a therapeutic tool?

Moderator:
-Mathew Cherian, ExCo Member, Industrial Pharmacy Section Consultant, USA

Panellists:
-Michael McCaman PhD (U Cal at Davis), Managing Director, BDO USA
-Seth Alexandert PhD (Yale), Associate Director, Resilience, USA

This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.

Learning objectives:
• Understand how hearing impairment or deafness impact a patient’s quality of life and their capacity to communicate with healthcare professionals.
• Learn about what pharmacists can do to support patients and carers with these conditions.
• Improve communication strategies to advise patients with hearing impairment on how to achieve an optimal use of medicines and medical devices.

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region join us for a true regional perspective.

About the programme - FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. 

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

In 2021, in our continued response to the COVID-19 global health crisis, FIP has launched a global digital events programme titled: “Collaborating through the pandemic- working & learning together”.
The programme will showcase a number of virtual events – e.g. webinars- under various and relevant topics to the pandemic and the pharmacy profession.
A special weekly programme will be delivered throughout the year, starting April 2021.
This programme is open-access to all (upon registration) and targets all members of the pharmaceutical workforce from around the world.

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.


At the end of this webinar, participants will:

1. Recognize the role of pharmacists in the screening and detection of diabetes
2. Become familiar with services that pharmacists can provide in promoting the awareness of diabetes and adoption of healthy lifestyle
3. Describe how the pandemic has influenced the delivery of diabetes services by pharmacists.

There is a growing understanding about the role of pharmacists in anticoagulation management. Pharmacists are able to bring to bear their expert knowledge of medicine in managing anticoagulation therapy, thereby improving patient outcomes. Other roles of pharmacists include the provision of patient education, identification of drug interactions and monitoring for adverse effects. This webinar will explore the various roles that pharmacists can play in providing anticoagulation management services.

At the end of this webinar, participants will:
1. Identify the different issues impacting anticoagulation management
2. Recognize the crucial role of pharmacists in enhancing the management of anticoagulation
3. Explain the role technology can play in supporting anticoagulation management
4. Describe the barriers and opportunities for pharmacists in leading anticoagulation management services

In the third of six regions we dissect, event 8 focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

As diverse as the pharmacy profession is, each area of practice comes with its perks. This digital event seeks to provide attendees with information on diverse career paths and opportunities in pharmacy and the pharmaceutical sciences. 

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event will gather different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Learning objectives:
1. Understand the role of the various civil society organisations in contributing to increased vaccination coverage.
2. Explore drivers and barriers to diversifying vaccination pathways and providers, allowing for better access to vaccination services.
3. Discuss possible actions and synergies by the different stakeholders in addressing vaccine hesitancy and complacency.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Describe the different services provided by pharmacists to manage diabetes
• Identify the role of pharmacists in preventing the complications of diabetes
• Understand the importance of collaboration with other diabetes health professionals in achieving treatment goals

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Describe the advancement in diabetes therapeutics for managing diabetes
• Explain the role of technology in improving health outcome of individuals living with diabetes
• Identify the different services employed in the optimization of diabetes treatment

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.


At the end of this webinar, participants will:

• Understand the strategies for developing a diabetes competent workforce
• Learn from successful experiences on how to develop competency framework for diabetes related roles
• Identify relevant competencies facilitating the delivery of diabetes services

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Identify the challenges and opportunities for pharmacists in addressing diabetes
• Recognize the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes services
• Understand how the role of pharmacists can be elevated in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD)

Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.

At the end of this session, participants will be able to:
1. Define implicit bias and its impact on health disparities.
2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues.
3. Identify and reflect on own biases.
4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.

Moderator:
- Mohamed Amin, Associate Professor, Beirut Arab University - Lebanon
- Dalia Bajis, FIP lead for Provision and Partnerships, FIP - Bahrain
- Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center - USA

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

This event will run twice on the same day so that we provide a uniting set of outcomes and provide equitable times for attendance across hemispheres.

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

This event will run twice on the same day so that we provide a uniting set of outcomes and provide equitable times for attendance across hemispheres.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Americas region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Western Pacific region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the African region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the South East Asian region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Eastern Mediterranean region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In 2020 Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events where we combined our efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives for AMR mitigation. The success of this partnership culminated in the FIP regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share a global commitment in the fight against AMR as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for Pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the European region over the last 12 months.

You are invited to participate in submitting your initiative through this platform. Your information will remain confidential. Please click here: https://fip-grip-events-2021.questionpro.com

In this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections and the care and support to people living with HIV. Pharmacists can play an important support role for people living with HIV, through the management of their medication, education for prevention and treatment, but also through HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Learning objectives:
1. Describe the burden and characteristics of HIV globally.
2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV.
3. Describe the role of pharmacists in PrEP-related services.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

The Global Advanced development framework (GADF) was developed to support the professional development and recognition of the pharmacy workforce everywhere and the Global Competency Framework (GbCF) was developed by the FIP as a focused support structure for early career pharmacists.  This digital event seeks to create more awareness for the GADF and GbCF and to enable young pharmacists and pharmaceutical scientists have a better understanding of their structure.

This is an important event in the region due to the presence of international, well-known, keynote speakers and the participation and support of international associations. The event will bring together regulatory and science key professionals as well pharmaceutical industry and academia to share experiences, perspectives, insights and the latest regulation and technical development.

The Theme of this conference is the regulatory aspects related to bioequivalence and the objective is to discuss current international trends and updates in bioequivalence assessment, biowaivers, bioanalytics, dissolution and procedures. 

The conference will provide a unique opportunity for regulators, members of the pharmaceutical industry and academics in MENA region to interact with international experts and obtain information on current and innovative trends in the areas of bioequivalence, biowaivers, bioanalysis, and dissolution testing.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals